¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"NIH consensus development conference summary."¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® development ÇÑ±Û ¹ß´Þ, ¹ß»ý, ¹ßÀ°
¼³¸í   
  1. ¹ß´Þ. ½É½ÅÀÇ ÇüÅ¿͠Àç´ÉÀÇ »ó½ÂÀûÀΠº¯È­°úÁ¤. ¼ºÀå°ú ¸Å¿ì À¯»çÇÑ °³³äÀ¸·Î, ¶§·Î´Â °°Àº ¶æÀ¸·Î ¾²À̴ °æ¿ìµµ ÀÖ´Ù. ±×·¯³ª ¼ºÀåÀº °³Ã¼ÀÇ ¹ßÀ°¿¡ µû¸£´Â º¯È­, Áï °è¿­ÀûÀ¸·Î ¾çÀûÀΠÁõ°¡·Î¼­ ±â¼úÇϴ °æ¿ì¿¡ ¸¹ÀÌ ¾²À̰í, ¹ß´ÞÀº À̿͠°°Àº º¯È­¸¦ ¾çÀûÀΠ¸é»Ó¸¸ ¾Æ´Ï¶ó, ±¸Á¶³ª Àç´ÉÀÌ ºÐÈ­-º¹ÀâÈ­-Á¤¹ÐÈ­-À¯´ÉÈ­-ÅëÇÕÈ­µÇ¾î °¡´Â °ÍÀ¸·Î¼­ ±â¼úÇϴ °æ¿ì¿¡ ´õ¿í ¸¹ÀÌ ¾²À̴ °æÇâÀÌ ÀÖ´Ù. ±×¸®°í ¹ß´ÞÀ̶ó°í Çϴ °³³äÀº, À¯±âüÀÇ ¹ßÀ°¿¡ ´ëÇØ¼­¸¸ ¾²À̴ °ÍÀÌ ¾Æ´Ï¶ó, ¹«»ý¹°À̳ª ¹°¸®Àû-È­ÇÐÀû Çö»ó¿¡ ´ëÇØ¼­µµ ¶Ç´Â »çȸÀû-¹®È­Àû Çö»ó¿¡ ´ëÇØ¼­µµ ½Ã°£Àû º¯È­¹ßÀüÀ» ¼ö¹ÝÇϴ °æ¿ì¿¡ Àû¿ëµÇ´Â °³³äÀÌ´Ù. 2. ¹ßÀ°. ¹ßÀ°°úÁ¤¿¡´Â ´ÙÀ½°ú °°Àº ÀϹÝÀûÀΠ¿øÄ¢À» º¸ÀδÙ. ¨ç ¹ßÀ°Àº Áú¼­Á¤¿¬ÇϰԠÀÏÁ¤ÇÑ ¼ø¼­¸¦ °®´Â´Ù. ¨è ¹ßÀ°Àº ¿¬¼ÓÀûÀ̳ª ÀÏÁ¤ÇÑ ¼Óµµ·Î ÁøÇàÇϴ °ÍÀº ¾Æ´Ï´Ù. ¨é ¹ßÀ°¿¡´Â ¹ßÀ°»ó Áß¿äÇÑ °¨¼ö±â¿Í ÀÓ°è±â°¡ ÀÖ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • conference
    Áý´ãȸ
  • cognitive development
    ÀÎÁö¹ß´Þ
  • communicative development
    ÀÇ»ç¼ÒÅë¹ß´Þ
  • community development
    Áö¿ª»çȸ°³¹ß
  • curriculum development
    ±³À°°úÁ¤°³¹ß
  • development
    1. Çö»ó 2. Àü°³ 3. ¹ß»ý, ¹ßÀ°, ¹ß´Þ 4. °³¹ß 5. ¹ß»ö
  • development quotient
    ¹ß´ÞÁö¼ö
  • direct development
    Á÷Á¢¹ßÀ°
  • ego development
    ÀھƹߴÞ
  • emotional development
    °¨Á¤¹ß´Þ
  • mental development
    Á¤½Å¹ß´Þ
  • psychosocial development
    Á¤½Å»çȸ¹ß´Þ
  • sexual development
    ¼º±â´É¹ß´Þ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • conference
    Áý´ãȸ
  • development
    ¹ß´Þ, ¹ß»ý, ¹ßÀ°
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • arrested development
    Á¤ÁöµÈ¹ß´Þ
  • cognitive development
    ÀÎÁö¹ß´Þ
  • communicative development
    ÀÇ»ç¼ÒÅë¹ß´Þ
  • community development
    Áö¿ª»çȸ°³¹ß
  • curriculum development
    ±³À°°úÁ¤ÀÛ¼º, ±³À°°úÁ¤°³¹ß
  • development
    ¹ß´Þ, ¹ß»ý, ¹ßÀ°
  • development quotient
    ¹ß´ÞÁö¼ö
  • digenetic development
    º¹¼¼´ë¹ßÀ°
  • direct development
    Á÷Á¢¹ßÀ°
  • ego development
    ÀھƹߴÞ
  • emotional development
    °¨Á¤¹ß´Þ
  • heterogonic development
    °£Á¢¹ßÀ°
  • homogonic development
    Á÷Á¢¹ßÀ°
  • mental development
    Áö´É¹ß´Þ
  • moral development
    µµ´ö¹ß´Þ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • NIH T cell
    NIH T¼¼Æ÷
  • arrested development
    ¹ß´ÞÁ¤Áö.
  • personality development
    ÀÎ°Ý ¹ß´Þ
  • postnatal development
    »ýÈĹßÀ°(¡­Û¡ëÀ).
  • prenatal development
    Ãâ»ýÀü¹ßÀ°(¡­Û¡ëÀ).
  • primary bone development
    ÀÏÂ÷»À¹ß»ý
  • psychosexual development
    Á¤½Å¼º ¹ß´Þ.
  • psychosocial development
    Á¤½Å»çȸÀû ¹ß´Þ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • well child conference
    ¾Æµ¿»ó´ã.
  • arrested development
    ¹ß´ÞÁ¤Áö.
  • atypical development
    ºñÁ¤Çü ¹ß´Þ
  • bone development =b. formation
    °ñ¹ß»ý(ÍéÛ¡ßæ).
  • child development
    ¼Ò¾Æ¹ß´Þ.
  • cognitive development
    ÀÎÁö¹ß´Þ(ìãò±Û¡Ó¹)
  • colo(u)r development
    ¹ß»ö.
  • communicative development
    ÀÇ»ç¼ÒÅë ¹ß´Þ(ëòÞÖáÂ÷×Û¡Ó¹)
  • community development
    Áö¿ª»çȸ°³¹ß (ÊÙ˧ËÑ).
  • curriculum development
    °úÁ¤ÀÛ¼º(Ë´ËøËöËÛ), °úÁ¤°³¹ß.
  • development
    ¹ß´Þ(Û¡Ó¹)
  • development
    ¹ß»ý, ¹ßÀ°(Û¡ëÀ), Àü°³(î÷ËÒ), Çö»ó(úÞßÀ).
  • development history
    ¹ßÀ°¿ª(»ç).
  • development quotient =DQ
    ¹ß´ÞÁö¼ö.
  • development quotient =DQ
    ¹ß´ÞÁö¼ö.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Membranous bone development
    ¸·»À¹ß»ý
    [¿¾ ¿ë¾î] ¸·¼º°ñ¹ß»ý
  • Primary bone development
    ÀÏÂ÷»À¹ß»ý
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñ¹ß»ý
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • consensus sequence
    °øÅë¼­¿­(Íì÷×ßíÖª)
  • NIH shift
    NIH À̵¿(ì¹ÔÑ)
  • continuous development
    ¿¬¼ÓÀü°³(ææáÙî÷ËÒ)
  • displacement development
    ´ëÄ¡Àü°³(ÓÛöÇî÷ËÒ) (ÔÒ) displacement chromatography
  • stepwise development
    ´Ü°èÀû Àü°³(Ó«Í­îÜî÷ËÒ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • summary
    ¿ä¾à
  • clinicopathological conference
    ÀÓ»ó.º´¸®°ËÅäȸ, ÀÓ»ó.º´¸®Åä·Ðȸ, ÀÓ»ó.º´¸®ÄÜÆÛ·±½º
  • CPC [=clinicopathological conference]
    ÀÓ»ó.º´¸®°ËÅäȸ
  • development
    ¹ß»ý, ¹ßÀ°, Àü°³, ¡ìÇʸ§ÀÇ¡íÇö»ó
  • growth and development
    ¼ºÀå°ú ¹ßÀ°
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
NDCG Nursing Development Conference Group
CONSENSUS Cooperative North Scandinavian Enalapril Survival Study
SCR Schick conversion rate; short consensus repeat; silicon-controlled rectifier; skin conductance respo...
DSD depression spectrum disease; discharge summary dictated; dry sterile dressing
SROC summary receiver operating characteristic
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ACGIH American Conference of Govermental Industrial Hygienists
I CH International Conference on Harmonization
MCS Mental Component Summary
( NIH National Institutes of Health
NIH Normalized Index of Hemolysis
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • JrId: 28024
    JournalTitle: NIH consensus development conference summary.
    MedAbbr: NIH Consens Dev Conf Summ
    ISSN: 0197-6133
    ESSN:
    IsoAbbr:
    NlmId: 8000583
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • summary
    ¿ä¾à
  • child development
    ¼Ò¾Æ ¹ß´Þ
  • cognitive development
    ÀÎÁöÀû ¹ß´Þ
  • development
    ¹ß»ý, ¹ßÀ°, Àü°³, Çö»ó
    1. ¹ß´Þ, ¹ß»ý, ¹ßÀ°, Çö»ó. ¹ßÀ°°ú ºÐÈ­ÀÇ °úÁ¤. 2. Çö»ö, Àü°³. 3. ³ë±¤¿¡ ÀÇÇØ °¨±¤¸·ÀÇ À¯Á¦¸· ¼Ó¿¡ »ý±ä Àá»óÀ» °¡½ÃÀÇ »óÀ¸·Î ¸¸µå´Â ÀÏ. ÃÔ¿µÀÌ ³¡³­ Çʸ§¿¡´Â ´«¿¡ º¸ÀÌÁö ¾ÊÀ¸³ª Àá»óÀ̶ó´Â ÇÇ»çü°¡ ±â·ÏµÇ¾î ÀÖ´Ù. ÀÌ¿Í °°ÀÌ ±â·ÏµÈ ´«¿¡ º¸ÀÌÁö ¾Ê´Â Çʸ§À» ¾Ï½Ç¿¡¼­ Çö»ó¾×À̶ó´Â ¾àǰ¿¡ ÀÏÁ¤½Ã°£ ´ã°¡µÎ¸é ´«¿¡ º¸ÀÌÁö ¾Ê´ø ±â·Ï È­»ó
  • development disorder
    ¹ßÀ° Àå¾Ö
  • development of speech and language
    ÀÇ»ç ¼ÒÅëÀÇ ¹ß´Þ
  • ectopoc development
    ÀÌ¼Ò ¹ßÀ°
  • embryonic development
    ¹è ¹ß»ý
  • ensitization 1. administration of antigen to induce a primary immune response; priming; immunization. 2. exposure to allergen that results in the development of hypersensitivity. 3. the coating of erythrocytes with antibody so that they are subject to lys
    ³»¹ø
    ƯÈ÷ ¾È°Ë ¿¬ÀÇ.
  • incomplete development
    ºÒ¿ÏÀüÇÑ ¹ßÀ°
  • personality development
    ¼º°Ý ¹ß´Þ
  • psychosexual development
    Á¤½Å¼º ¹ß´Þ
  • sensory development
    °¨°¢ ¹ß´Þ, Áö°¢ ¹ß´Þ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
consensus development conference Designation for summary statements representing the majority and current agreement of physicians, scientists, and other professionals meeting to reach a consensus on a selected subject.
(12 Dec 1998)
consensus development conferences, nih Articles on conferences sponsored by nih presenting summary statements representing the majority agreement of physicians, scientists, and other professionals convening for the purpose of reaching a consensus on a subject of interest. This heading is used for nih consensus conferences as a means of scientific communication. In indexing it is viewed as a type of review article and as a tag for any article appearing in any publication of the nih office of medical applications of research (omar).
(12 Dec 1998)
consensus development conferences Presentations of summary statements representing the majority agreement of physicians, scientists, and other professionals convening for the purpose of reaching a consensus--often with findings and recommendations--on a subject of interest. The conference, consisting of participants representing the scientific and lay viewpoints, is a significant means of evaluating current medical thought and reflects the latest advances in research for the respective field being addressed.
(12 Dec 1998)
clinical conference A conference of physicians on their observations of a patient at the bedside, regarding the physical state, laboratory and other diagnostic findings, clinical manifestations, results of current therapy, etc. A clinical conference usually ends with a confirmation or correction of clinical findings by a pathological diagnosis performed by a pathologist. "clinical conference" is often referred to as a "clinico-pathological conference."
(12 Dec 1998)
NIH The National Institutes of Health.
(12 Dec 1998)
NIH 3T3 cell <cell culture> Very widely used mouse fibroblast cell line, 3T3 cells have been derived from different mouse strains and it is therefore important to define the particular cell line. NIH strain were from the National Institute of Health in the USA.
(18 Nov 1997)
consensus sequence Of a series of related DNA, RNA or protein sequences, the sequence that reflects the most common choice of base or amino acid at each position. Areas of particularly good agreement often represent conserved functional domains. The generation of consensus sequences has been subjected to intensive mathematical analysis.
(18 Nov 1997)
Bayley Scales of Infant Development A psychological test used to measure the developmental progress of infants over the first two and one-half years of life; consists of three scales: mental, motor, and behaviour record.
(05 Mar 2000)
bone development Gross development of bones from foetus to adult. It includes osteogenesis, which is restricted to formation and development of bone from the undifferentiated cells of the germ layers of the embryo. It does not include osseointegration.
(12 Dec 1998)
maxillofacial development The process of growth and differentiation of the jaws and face.
(12 Dec 1998)
child development The continuous sequential physiological and psychological maturing of the child from birth up to but not including adolescence. It includes healthy responses to situations, but does not include growth in stature or size (= growth).
(12 Dec 1998)
child development disorders, pervasive Severe distortions in the development of many basic psychological functions that are not normal for any stage in development. These distortions are manifested in sustained social impairment, speech abnormalities, and peculiar motor movements.
(12 Dec 1998)
personality development Growth of habitual patterns of behaviour in childhood and adolescence.
(12 Dec 1998)
growth and embryonic development Developmental processes from cell division to embryogenesis to postnatal growth and maturity.
(12 Dec 1998)
pervasive development disorder <neurology, psychiatry> A large group of developmental disabilities which are neurological disorders, usually of unknown cause.
Characteristics include reduced abilities to understand language and communicate normally, reduced ability to socially interact with others in a normal manner, and limited variety in activities and interests. Individuals will also often respond in unusual ways to sensations, engage in repetitive activities, and resist changes to the environment or to daily routines.
Types of pervasive development disorder include autism, Retts Syndrome, Hellers Syndrome, and Aspergers Syndrome.
Acronym: PDD
(12 Jan 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • NIH
    National Institutesof Health(¹Ì)±¹¸³º¸°Ç¿ø
  • consensus
    ÀǰßÀÇ ÀÏÄ¡
  • consensus
    (Àǰß.Áõ¾ð µîÀÇ)ÀÏÄ¡;¿©·Ð;±³°¨
  • summary
    ¿ä¾àÇÑ
  • summary
    °³·«ÀÇ;°£°áÇÑ;¾à½ÄÀÇ;Áï°áÀÇ
  • summary
    Àû¿ä;¿ä¾à
  • conference
    ÇùÀÇ
  • Helsinki Conference
    Çï½ÌŰ ÇùÁ¤(1975³â µ¿¼­°£ÀÇ ±äÀå ¿ÏÈ­¸¦ À§ÇØ ¹Ì±¹,¼Ò·Ã µî 35°³±¹ÀÌ Á¶ÀÎ)
  • International Peace Conference
    ¸¸±¹ ÆòȭȸÀÇ(1899³â ÇìÀ̱׿¡¼­ ¿­¸°)
  • Yalta conference
    ¾âŸȸ´ã
  • conference
    ÇùÀÇ;»óÀÇ;ȸÀÇ;ÇùÀÇȸ;ÇØ¿î µ¿¸Í;°æ±â¿¬¸Í;¼ö¿©
  • conference call
    (¿©·µÀÌ ÇÏ´Â)ÀüȭȸÀÇ
  • conference lines
    È÷¿î µ¿¸Í Ç×·Î(ÇØ¿î¾÷ÀÚ°¡ °øµ¿ ÀÌÀÍÀ» À§ÇÏ¿© µ¶ÀÚÀû ¼­ºñ½º¸¦ ¾Ê±â·Î ¾àÁ¤ÇÑ Ç×·Î)
  • news conference
    (ƯÈ÷ Á¤ºÎ °í°ü µîÀÇ) ±âÀÚȸ°ß
  • peace conference(congress)
    ÆòÈ­ ȸÀÇ;°­È­ ȸÀÇ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á